Medmen Enterprises Inc Class B Subordin (MMEN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3,231 | 3,500 | 3,971 | 7,422 | 2,383 |
| Income taxes - deferred | 0 | 0 | 0 | -6,416 | 2,459 |
| Accounts receivable | -665 | 2,894 | 2,164 | 1,858 | -201 |
| Accounts payable and accrued liabilities | 9,619 | 9,406 | -1,746 | 10,147 | -3,627 |
| Other Working Capital | -608 | 3,536 | 13,095 | 6,596 | -3,227 |
| Other Operating Activity | -26,416 | -18,060 | -27,094 | -16,781 | -13,677 |
| Operating Cash Flow | $-14,839 | $1,276 | $-9,610 | $2,826 | $-15,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,838 | -5,974 | 0 | -6,683 | 4,725 |
| Purchase Sale Intangibles | 4,819 | -7 | -24 | -616 | 487 |
| Other Investing Activity | 4,089 | 0 | 51,500 | 1,127 | -2,345 |
| Investing Cash Flow | $5,927 | $-5,981 | $51,476 | $-6,173 | $2,867 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -32,751 | 31,602 | -31,602 | -2,873 | -19,999 |
| Other Financing Activity | 32,351 | -32,388 | 38 | 2,609 | 0 |
| Financing Cash Flow | $-400 | $-787 | $-31,565 | $-264 | $-19,999 |
| Beginning Cash Position | 15,605 | 21,097 | 10,796 | 14,411 | 47,724 |
| End Cash Position | 7,626 | 15,605 | 21,097 | 10,796 | 14,411 |
| Net Cash Flow | $-9,311 | $-5,492 | $10,301 | $-3,612 | $-33,021 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,839 | 1,276 | -9,610 | 2,826 | -15,890 |
| Capital Expenditure | N/A | -5,981 | -24 | -7,299 | N/A |
| Free Cash Flow | -14,839 | -4,705 | -9,634 | -4,474 | -15,890 |